Transgene Aktie

0,64EUR -0,10EUR -13,73%
Transgene für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN: 913048 / ISIN: FR0005175080

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>

Personal

2020 2021 2022 2023 2024
Personal am Ende des Jahres 165 167 167 158 0
Umsatz pro Mitarbeiter in Mio. EUR 0,02 0,06 0,02 0,01 0,00

Bilanz (in Mio. EUR) - Aktiva

2020 2021 2022 2023 2024
Summe Umlaufvermögen 31 62 47 18 21
Summe Anlagevermögen 55 40 20 27 22
Summe Aktiva 85 102 66 45 42

Bilanz (in Mio. EUR) - Passiva

2020 2021 2022 2023 2024
Summe Fremdkapital 35 35 29 30 27
Summe Eigenkapital 50 67 38 16 15
Summe Passiva 85 102 66 45 42

Adresse

400, boulevard Gonthier d'Andernach, 67405 Strasbourg
Telefon +33 (3) 88-27-91-00
Fax +33 (3) 88-27-91-11
Internet http://www.transgene.fr

Management

Alain Mérieux
Honorary Chairman
Alessandro Riva
Chairman & Chief Executive Officer
Benoît Habert
Independent Director
Carol Stuckley
Independent Director
Christelle Schwoerer
Chief Human Resources Officer
Christophe Ancel
VP-Pharmaceutical Operations
Emmanuelle Dochy
Chief Medical Officer
James Wentworth
Chief Business Officer & Vice President
Jean-Luc Bélingard
Director
Jean-Yves Blay
Independent Director
John Felitti
Secretary, Vice President & General Counsel
Lucie Larguier
CFO, Director-Corporate Communications & IR
Marie-Yvonne Landel-Meunier
Independent Director
Maurizio Ceppi
Chief Scientific Officer
Maya R. Said
Independent Director
Michel Baguenault de Puchesse
Director
Philippe Archinard
Director
Sandrine Flory
Director